Documents & Downloads

Dregamine

Antitumor agent

Dregamine is a monoterpene indole compound known for its ability to induce apoptosis in cancer cells. This compound exhibits significant antitumor activity, making it a valuable candidate for cancer research and therapeutic applications. Researchers can utilize Dregamine to investigate its effects on cell viability and apoptosis pathways in various cancer models.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	2299-26-5
Applications	Antitumor agent
Formula	C₂₁H₂₆N₂O₃
Molecular Weight	354.44
SMILES	O=C1C2=C(C[C@@]3([H])[C@H]([C@@](C(CN3C)CC)([H])C1)C(OC)=O)C4=CC=CC=C4N2

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.